Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Collegium Pharmaceutical, Inc.

Collegium to Participate in Upcoming Investor Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium Announces $25 Million Accelerated Share Repurchase Program
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium Announces Updates to its Board of Directors and Executive Leadership Team
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium to Participate in Upcoming Investor Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium Appoints Nancy S. Lurker to its Board of Directors
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium Provides 2025 Financial Guidance and Business Update
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium to Participate in Upcoming Investor Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium Reports Record Third Quarter 2024 Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium Appoints Vikram Karnani as Chief Executive Officer
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium Completes Acquisition of Ironshore Therapeutics
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium Reports Second Quarter 2024 Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium to Participate in Jefferies Global Healthcare Conference
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium Announces $35 Million Accelerated Share Repurchase Program
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium Reports First Quarter 2024 Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium Announces CEO Transition
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Collegium to Report First Quarter 2024 Financial Results on May 9, 2024
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.